Bank of America
COLL icon

Bank of America’s Collegium Pharmaceutical COLL Stock Holding History

Bank of America’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.85M Buy
297,847
+102,502
+52% +$4.34M ﹤0.01% 2972
2025
Q4 		$9.04M Sell
195,345
-50,423
-21% -$2.11M ﹤0.01% 2934
2025
Q3 		$8.6M Sell
245,768
-269,039
-52% -$9.35M ﹤0.01% 3454
2025
Q2 		$15.2M Buy
514,807
+62,274
+14% +$1.78M ﹤0.01% 2823
2025
Q1 		$13.5M Buy
452,533
+366,437
+426% +$11.2M ﹤0.01% 2843
2024
Q4 		$2.47M Sell
86,096
-36,093
-30% -$1.19M ﹤0.01% 4259
2024
Q3 		$4.72M Sell
122,189
-8,636
-7% -$308K ﹤0.01% 3784
2024
Q2 		$4.21M Sell
130,825
-67,673
-34% -$2.35M ﹤0.01% 3779
2024
Q1 		$7.71M Buy
198,498
+179,952
+970% +$6.3M ﹤0.01% 3229
2023
Q4 		$571K Sell
18,546
-25,707
-58% -$644K ﹤0.01% 5396
2023
Q3 		$989K Buy
44,253
+12,163
+38% +$277K ﹤0.01% 4823
2023
Q2 		$690K Buy
32,090
+5,353
+20% +$122K ﹤0.01% 5042
2023
Q1 		$641K Sell
26,737
-6,816
-20% -$181K ﹤0.01% 5204
2022
Q4 		$778K Buy
33,553
+16,142
+93% +$325K ﹤0.01% 5050
2022
Q3 		$279K Sell
17,411
-13,263
-43% -$234K ﹤0.01% 5776
2022
Q2 		$543K Sell
30,674
-27,053
-47% -$455K ﹤0.01% 5382
2022
Q1 		$1.18M Buy
57,727
+33,405
+137% +$631K ﹤0.01% 5078
2021
Q4 		$454K Buy
24,322
+681
+3% +$13.3K ﹤0.01% 5962
2021
Q3 		$468K Sell
23,641
-14,071
-37% -$304K ﹤0.01% 5694
2021
Q2 		$891K Sell
37,712
-18,605
-33% -$430K ﹤0.01% 5002
2021
Q1 		$1.33M Buy
56,317
+41,839
+289% +$994K ﹤0.01% 4587
2020
Q4 		$290K Sell
14,478
-36,752
-72% -$718K ﹤0.01% 5362
2020
Q3 		$1.07M Buy
51,230
+32,826
+178% +$592K ﹤0.01% 4156
2020
Q2 		$322K Buy
18,404
+4,562
+33% +$89.3K ﹤0.01% 4942
2020
Q1 		$226K Sell
13,842
-597
-4% -$12.3K ﹤0.01% 5013
2019
Q4 		$297K Sell
14,439
-19,158
-57% -$319K ﹤0.01% 5367
2019
Q3 		$386K Buy
33,597
+7,070
+27% +$80.7K ﹤0.01% 5254
2019
Q2 		$350K Sell
26,527
-6,784
-20% -$90.7K ﹤0.01% 5303
2019
Q1 		$505K Buy
33,311
+9,330
+39% +$149K ﹤0.01% 5011
2018
Q4 		$412K Buy
23,981
+3,525
+17% +$60.3K ﹤0.01% 5062
2018
Q3 		$302K Buy
20,456
+2,011
+11% +$35.6K ﹤0.01% 5256
2018
Q2 		$440K Buy
18,445
+5,162
+39% +$127K ﹤0.01% 4973
2018
Q1 		$339K Buy
13,283
+3,486
+36% +$83.1K ﹤0.01% 5070
2017
Q4 		$180K Buy
9,797
+449
+5% +$6.43K ﹤0.01% 5461
2017
Q3 		$98K Buy
9,348
+4,124
+79% +$45.5K ﹤0.01% 5684
2017
Q2 		$65K Sell
5,224
-791
-13% -$7.82K ﹤0.01% 5777
2017
Q1 		$61K Buy
6,015
+723
+14% +$10.7K ﹤0.01% 5831
2016
Q4 		$82K Buy
5,292
+4,584
+647% +$76.2K ﹤0.01% 5714
2016
Q3 		$13K Sell
708
-961
-58% -$11.4K ﹤0.01% 6287
2016
Q2 		$20K Sell
1,669
-3,908
-70% -$64.6K ﹤0.01% 6248
2016
Q1 		$101K Sell
5,577
-61,275
-92% -$1.11M ﹤0.01% 5478
2015
Q4 		$1.84M Buy
66,852
+55,794
+505% +$1.18M ﹤0.01% 3874
2015
Q3 		$244K Buy
11,058
+10,874
+5,910% +$197K ﹤0.01% 5224
2015
Q2 		$3K Buy
+184
New +$3.18K ﹤0.01% 6956

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bank of America's COLL Position: Q1 2026 in Review

Bank of America increased its Collegium Pharmaceutical (COLL) stake by 52% in Q1 2026, buying an estimated $4.34M and bringing the position to 297,847 shares worth $9.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2972.

Bank of America first reported a position in COLL in Q2 2015 and has held it in 44 quarters since. The position peaked at $15.2M in Q2 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Bank of America held 297,847 shares of Collegium Pharmaceutical worth $9.85M as of Q1 2026.
  • Bank of America bought 102,502 Collegium Pharmaceutical shares in Q1 2026, an estimated $4.34M.
  • Collegium Pharmaceutical made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2972 holding.
  • Bank of America first reported a position in Collegium Pharmaceutical in Q2 2015 and has held it in 44 quarters since.
  • Bank of America's Collegium Pharmaceutical position peaked at $15.2M in Q2 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.